Yujiro Nakano

1.4k total citations
45 papers, 1.0k citations indexed

About

Yujiro Nakano is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Yujiro Nakano has authored 45 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Surgery and 16 papers in Epidemiology. Recurrent topics in Yujiro Nakano's work include Liver Disease Diagnosis and Treatment (12 papers), Cardiovascular Disease and Adiposity (6 papers) and Adrenal and Paraganglionic Tumors (6 papers). Yujiro Nakano is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Cardiovascular Disease and Adiposity (6 papers) and Adrenal and Paraganglionic Tumors (6 papers). Yujiro Nakano collaborates with scholars based in Japan, Canada and Denmark. Yujiro Nakano's co-authors include Takanobu Yoshimoto, Yoshihiro Ogawa, Masanori Murakami, Ryotaro Bouchi, Isao Minami, Koshi Hashimoto, Takato Takeuchi, Hajime Izumiyama, Tatsuya Fukuda and M Asakawa and has published in prestigious journals such as Diabetes Care, Diabetes and Biochemical and Biophysical Research Communications.

In The Last Decade

Yujiro Nakano

43 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yujiro Nakano Japan 16 440 336 335 294 258 45 1.0k
Ananda Basu United States 17 341 0.8× 381 1.1× 186 0.6× 171 0.6× 166 0.6× 33 942
Sílvia Pellitero Spain 21 320 0.7× 422 1.3× 148 0.4× 390 1.3× 278 1.1× 57 1.1k
Irene E. Schauer United States 17 518 1.2× 217 0.6× 171 0.5× 239 0.8× 113 0.4× 37 951
Hajime Izumiyama Japan 25 861 2.0× 386 1.1× 376 1.1× 613 2.1× 287 1.1× 57 1.7k
Müjde Aktürk Türkiye 21 413 0.9× 203 0.6× 123 0.4× 187 0.6× 166 0.6× 80 1.1k
Fotios Iliadis Greece 16 270 0.6× 310 0.9× 226 0.7× 125 0.4× 253 1.0× 30 954
Petra Kaválková Czechia 21 158 0.4× 410 1.2× 220 0.7× 321 1.1× 269 1.0× 55 1.3k
Robyn A. Tamboli United States 14 255 0.6× 729 2.2× 163 0.5× 639 2.2× 293 1.1× 26 1.2k
A. Scarda Italy 14 243 0.6× 327 1.0× 144 0.4× 250 0.9× 233 0.9× 17 1.0k
M.K. Palmer Sweden 19 388 0.9× 453 1.3× 244 0.7× 473 1.6× 198 0.8× 35 1.6k

Countries citing papers authored by Yujiro Nakano

Since Specialization
Citations

This map shows the geographic impact of Yujiro Nakano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yujiro Nakano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yujiro Nakano more than expected).

Fields of papers citing papers by Yujiro Nakano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yujiro Nakano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yujiro Nakano. The network helps show where Yujiro Nakano may publish in the future.

Co-authorship network of co-authors of Yujiro Nakano

This figure shows the co-authorship network connecting the top 25 collaborators of Yujiro Nakano. A scholar is included among the top collaborators of Yujiro Nakano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yujiro Nakano. Yujiro Nakano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nishiuchi, Takumi, Hisanori Goto, Yujiro Nakano, et al.. (2025). Cysteine redoxome landscape in mouse brown adipose tissue under acute cold exposure. iScience. 28(3). 112051–112051. 1 indexed citations
2.
Goto, Hisanori, et al.. (2024). Thyroid Arteriovenous Malformation in Hereditary Hemorrhagic Telangiectasia: Insights on Successful Noninvasive Imaging. JCEM Case Reports. 2(8). luae138–luae138. 1 indexed citations
3.
Ishii, Kiyo‐aki, Hiroaki Takayama, Jun Hamazaki, et al.. (2023). PAC1 Deficiency Protects Obese Male Mice From Immobilization-Induced Muscle Atrophy by Suppressing FoxO–Atrogene Axis. Endocrinology. 164(6). 4 indexed citations
4.
Takeshita, Yumie, Hiroaki Takayama, Hisanori Goto, et al.. (2023). Trajectories of Liver Fibrosis and Gene Expression Profiles in Nonalcoholic Fatty Liver Disease Associated With Diabetes. Diabetes. 72(9). 1297–1306. 12 indexed citations
5.
6.
Takeshita, Yumie, Hiromasa Tsujiguchi, Takayuki Kannon, et al.. (2023). Nutrigenetic Interaction Between Apolipoprotein C3 Polymorphism and Fat Intake in People with Nonalcoholic Fatty Liver Disease. Current Developments in Nutrition. 7(4). 100051–100051. 4 indexed citations
7.
8.
Nakano, Yujiro, Takeo Tanaka, Kosuke R. Shima, et al.. (2022). Somatostatin Receptor-negative and Fluorodeoxyglucose-positron Emission Tomography-positive Lung Neuroendocrine Tumor G1 Exhibiting Cyclic Cushing's Syndrome. Internal Medicine. 61(24). 3693–3698. 4 indexed citations
9.
Takeshita, Yumie, Hiroaki Takayama, Kiyo‐aki Ishii, et al.. (2021). Effects of eicosapentaenoic acid on serum levels of selenoprotein P and organ‐specific insulin sensitivity in humans with dyslipidemia and type 2 diabetes. Journal of Diabetes Investigation. 13(3). 532–542. 4 indexed citations
10.
Nakano, Yujiro, Chikara Komiya, Hiroyuki Mishima, et al.. (2020). A case of ezetimibe-effective hypercholesterolemia with a novel heterozygous variant in <i>ABCG5</i>. Endocrine Journal. 67(11). 1099–1105. 3 indexed citations
11.
Nakano, Yujiro, Koshi Hashimoto, Isao Minami, et al.. (2019). A Case of Refractory Hypothyroidism due to Poor Compliance Treated with the Weekly Intravenous and Oral Levothyroxine Administration. Case Reports in Endocrinology. 2019. 1–6. 8 indexed citations
12.
Fukuda, Tatsuya, Ryotaro Bouchi, Masahiro Terashima, et al.. (2017). Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot Study. Diabetes Therapy. 8(4). 851–861. 97 indexed citations
13.
Fukuda, Tatsuya, Ryotaro Bouchi, Takato Takeuchi, et al.. (2017). Ratio of visceral‐to‐subcutaneous fat area predicts cardiovascular events in patients with type 2 diabetes. Journal of Diabetes Investigation. 9(2). 396–402. 45 indexed citations
14.
Bouchi, Ryotaro, Masahiro Terashima, Yuriko Sasahara, et al.. (2017). Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: a pilot study. Cardiovascular Diabetology. 16(1). 32–32. 139 indexed citations
15.
Bouchi, Ryotaro, Yujiro Nakano, Takato Takeuchi, et al.. (2016). Clinical relevance of dual-energy X-ray absorptiometry (DXA) as a simultaneous evaluation of fatty liver disease and atherosclerosis in patients with type 2 diabetes. Cardiovascular Diabetology. 15(1). 64–64. 28 indexed citations
16.
17.
Murakami, Masanori, Takanobu Yoshimoto, Yujiro Nakano, et al.. (2016). Expression of inflammation-related genes in aldosterone-producing adenomas with KCNJ5 mutation. Biochemical and Biophysical Research Communications. 476(4). 614–619. 5 indexed citations
18.
Bouchi, Ryotaro, M Asakawa, Yujiro Nakano, et al.. (2016). Is visceral adiposity a modifier for the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes?. Cardiovascular Diabetology. 15(1). 10–10. 13 indexed citations
19.
Bouchi, Ryotaro, Takato Takeuchi, Yujiro Nakano, et al.. (2015). High visceral fat with low subcutaneous fat accumulation as a determinant of atherosclerosis in patients with type 2 diabetes. Cardiovascular Diabetology. 14(1). 136–136. 65 indexed citations
20.
Bouchi, Ryotaro, Isao Minami, Yujiro Nakano, et al.. (2015). Impact of increased visceral adiposity with normal weight on the progression of arterial stiffness in Japanese patients with type 2 diabetes. BMJ Open Diabetes Research & Care. 3(1). e000081–e000081. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ananda Basu Breakdown of academic impact, for papers by Sílvia Pellitero Breakdown of academic impact, for papers by Irene E. Schauer Breakdown of academic impact, for papers by Hajime Izumiyama Breakdown of academic impact, for papers by Müjde Aktürk Breakdown of academic impact, for papers by Fotios Iliadis Breakdown of academic impact, for papers by Petra Kaválková Breakdown of academic impact, for papers by Robyn A. Tamboli Breakdown of academic impact, for papers by A. Scarda Breakdown of academic impact, for papers by M.K. Palmer
Rankless by CCL
2026